Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study

NCT00810888 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT00810888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2016
Enrollment
92 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage